HY

Hyundai ADM Bio lnc.

Korean CRO offering end-to-end clinical trial services for pharma & bio ventures.

187660 | KO

Overview

Corporate Details

ISIN(s):
KR7187660006
LEI:
Country:
South Korea
Address:
서울특별시 종로구 새문안로5길 19, 7층 711호(당주동, 로얄빌딩), 종로구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Hyundai ADM Bio Inc. is a leading Korean Contract Research Organization (CRO) providing comprehensive clinical trial services to pharmaceutical companies and bio ventures. The company offers end-to-end support across all study phases, specializing in clinical operations and medical writing to ensure high-quality, globally standardized trial execution. Leveraging extensive experience and a track record of successful clinical trials, Hyundai ADM Bio positions itself as a key partner in drug development. In addition to its CRO services, the company engages in its own research and development, notably advancing the anti-cancer drug candidate 'Penitrium' in collaboration with its parent company, Hyundai Bioscience.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-03 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 100.9 KB
2025-09-01 00:00
Share Issue/Capital Change
전환청구권행사
Korean 10.8 KB
2025-08-20 00:00
Share Issue/Capital Change
주요사항보고서(제3자의전환사채매수선택권행사)
Korean 41.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-08-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 93.6 KB
2025-08-07 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-07-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 13.4 KB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 18.4 KB
2025-07-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 16.4 KB
2025-07-31 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 18.6 KB
2025-07-31 00:00
Board/Management Information
대표이사변경
Korean 15.3 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 68.0 KB
2025-07-16 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의 (임시주주총회)
Korean 20.9 KB
2025-07-14 00:00
Share Issue/Capital Change
전환청구권행사
Korean 9.0 KB
2025-07-03 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB

Automate Your Workflow. Get a real-time feed of all Hyundai ADM Bio lnc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hyundai ADM Bio lnc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hyundai ADM Bio lnc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Interworks Confidence Inc. Logo
Specialized staffing and recruitment for the game, entertainment, and manufacturing sectors.
Japan
7374
INTLOOP Inc. Logo
Offers consulting, tech, and HR solutions leveraging a vast freelance professional network.
Japan
9556
IntoCell, Inc. Logo
Develops and licenses proprietary ADC platform technologies for cancer & immune therapies.
South Korea
287840
Intracom S.A. Holdings Logo
A multinational group delivering IT solutions, defense electronics, and construction projects.
Greece
INTRK
Inventionmed Spolka Akcyjna Logo
Develops VR medical simulators with haptic feedback for dermatology training.
Poland
INM
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
A CRO advancing precision medicine via genomic analysis and clinical trial support services.
South Korea
216400
IQVIA HOLDINGS INC. Logo
Global provider of analytics, tech, and clinical research for life sciences and healthcare.
United States of America
IQV
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden
ISOFOL
B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.
South Korea
052770

Talk to a Data Expert

Have a question? We'll get back to you promptly.